These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 19019970

  • 21. Efficacy of a multigenic protein vaccine containing multimeric HIV gp160 against heterologous SHIV clade C challenges.
    Rasmussen RA, Ong H, Song R, Chenine AL, Ayash-Rashkovsky M, Hu SL, Polacino P, Else JG, Novembre FJ, Ruprecht RM, Clade C Program Project.
    AIDS; 2007 Sep 12; 21(14):1841-8. PubMed ID: 17721091
    [Abstract] [Full Text] [Related]

  • 22. Construction and characterization of a new simian/human immunodeficiency viruses clone carrying an env gene derived from a CRF07_BC strain.
    Li Y, Yang GB, Chen QM, Liu Q, Meng ZF, Geng YQ, Qiao WT, Shao YM.
    Chin Med J (Engl); 2009 Dec 05; 122(23):2874-9. PubMed ID: 20092794
    [Abstract] [Full Text] [Related]

  • 23. Novel Transmitted/Founder Simian-Human Immunodeficiency Viruses for Human Immunodeficiency Virus Latency and Cure Research.
    Bauer AM, Ziani W, Lindemuth E, Kuri-Cervantes L, Li H, Lee FH, Watkins M, Ding W, Xu H, Veazey R, Bar KJ.
    J Virol; 2020 Mar 31; 94(8):. PubMed ID: 31969435
    [Abstract] [Full Text] [Related]

  • 24. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K, Cecilia D, Ami Y, Nakasone T, Matsuo K, Burda S, Yamamoto H, Yoshino N, Kaizu M, Ando S, Okuda K, Zolla-Pazner S, Yamazaki S, Yamamoto N, Honda M.
    J Virol; 2005 Feb 31; 79(3):1452-62. PubMed ID: 15650171
    [Abstract] [Full Text] [Related]

  • 25. In vivo analysis of a new R5 tropic SHIV generated from the highly pathogenic SHIV-KS661, a derivative of SHIV-89.6.
    Matsuda K, Inaba K, Fukazawa Y, Matsuyama M, Ibuki K, Horiike M, Saito N, Hayami M, Igarashi T, Miura T.
    Virology; 2010 Mar 30; 399(1):134-143. PubMed ID: 20102777
    [Abstract] [Full Text] [Related]

  • 26. A CCR5-tropic simian-HIV molecular clone capable of inducing AIDS in rhesus macaques.
    Hsu M, Ho SH, Balfe P, Gettie A, Harouse J, Blanchard J, Cheng-Mayer C.
    J Acquir Immune Defic Syndr; 2005 Dec 01; 40(4):383-7. PubMed ID: 16280691
    [Abstract] [Full Text] [Related]

  • 27. Rapid CD4+ T-lymphocyte depletion in rhesus monkeys infected with a simian-human immunodeficiency virus expressing the envelope glycoproteins of a primary dual-tropic Ethiopian Clade C HIV type 1 isolate.
    Cayabyab M, Rohne D, Pollakis G, Mische C, Messele T, Abebe A, Etemad-Moghadam B, Yang P, Henson S, Axthelm M, Goudsmit J, Letvin NL, Sodroski J.
    AIDS Res Hum Retroviruses; 2004 Jan 01; 20(1):27-40. PubMed ID: 15000696
    [Abstract] [Full Text] [Related]

  • 28. Characterization of a simian human immunodeficiency virus encoding the envelope gene from the CCR5-tropic HIV-1 Ba-L.
    Pal R, Taylor B, Foulke JS, Woodward R, Merges M, Praschunus R, Gibson A, Reitz M.
    J Acquir Immune Defic Syndr; 2003 Jul 01; 33(3):300-7. PubMed ID: 12843740
    [Abstract] [Full Text] [Related]

  • 29. Infectious simian/human immunodeficiency virus with human immunodeficiency virus type 1 subtype C from an African isolate: rhesus macaque model.
    Ndung'u T, Lu Y, Renjifo B, Touzjian N, Kushner N, Pena-Cruz V, Novitsky VA, Lee TH, Essex M.
    J Virol; 2001 Dec 01; 75(23):11417-25. PubMed ID: 11689623
    [Abstract] [Full Text] [Related]

  • 30. Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose.
    Sholukh AM, Byrareddy SN, Shanmuganathan V, Hemashettar G, Lakhashe SK, Rasmussen RA, Watkins JD, Vyas HK, Thorat S, Brandstoetter T, Mukhtar MM, Yoon JK, Novembre FJ, Villinger F, Landucci G, Forthal DN, Ratcliffe S, Tuero I, Robert-Guroff M, Polonis VR, Bilska M, Montefiori DC, Johnson WE, Ertl HC, Ruprecht RM.
    Retrovirology; 2014 Jan 20; 11():8. PubMed ID: 24444350
    [Abstract] [Full Text] [Related]

  • 31. Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission.
    Gonzalez MW, DeVico AL, Lewis GK, Spouge JL.
    J Virol; 2015 Apr 20; 89(7):3619-29. PubMed ID: 25589663
    [Abstract] [Full Text] [Related]

  • 32. Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.
    Hsu M, Harouse JM, Gettie A, Buckner C, Blanchard J, Cheng-Mayer C.
    J Virol; 2003 Jan 20; 77(2):989-98. PubMed ID: 12502815
    [Abstract] [Full Text] [Related]

  • 33. Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.
    Endo Y, Igarashi T, Nishimura Y, Buckler C, Buckler-White A, Plishka R, Dimitrov DS, Martin MA.
    J Virol; 2000 Aug 20; 74(15):6935-45. PubMed ID: 10888632
    [Abstract] [Full Text] [Related]

  • 34. Generation of lineage-related, mucosally transmissible subtype C R5 simian-human immunodeficiency viruses capable of AIDS development, induction of neurological disease, and coreceptor switching in rhesus macaques.
    Ren W, Mumbauer A, Gettie A, Seaman MS, Russell-Lodrigue K, Blanchard J, Westmoreland S, Cheng-Mayer C.
    J Virol; 2013 Jun 20; 87(11):6137-49. PubMed ID: 23514895
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Although macrophage-tropic simian/human immunodeficiency viruses can exhibit a range of pathogenic phenotypes, a majority of isolates induce no clinical disease in immunocompetent macaques.
    Igarashi T, Donau OK, Imamichi H, Nishimura Y, Theodore TS, Iyengar R, Erb C, Buckler-White A, Buckler CE, Martin MA.
    J Virol; 2007 Oct 20; 81(19):10669-79. PubMed ID: 17626082
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.